Takato Nishino
Papers
4
Total Citations
10
H-Index
2
About
Dr. Takato Nishino is a urologic surgeon and researcher whose work centers on optimizing surgical and oncological outcomes for high-risk prostate cancer, particularly through robot-assisted radical prostatectomy (RARP). His major contributions include rigorous evaluations of extended lymph node dissection (ePLND) and neoadjuvant hormonal therapy, challenging established practices. A 2025 study (4 citations) found that ePLND may not provide a therapeutic benefit for biochemical recurrence in intermediate-to high-risk patients, while a multicenter propensity-matched analysis (3 citations) demonstrated the efficacy of neoadjuvant hormonal therapy for high-risk cases in Japan. Dr. Nishino has also advanced surgical technique, notably by optimizing first trocar access for the da Vinci X/Xi system using optical trocar entry through the upper abdominal quadrant (2 citations). His 2025 comparison of neoadjuvant chemohormonal therapy versus pelvic lymphadenectomy (1 citation) further refines treatment strategies for very-high-risk disease. By combining retrospective multicenter data with technical innovation, Dr. Nishino provides evidence-based guidance for urologists navigating the complex landscape of aggressive prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4